Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8828 |
High Similarity |
NPD2534 |
Approved |
0.8828 |
High Similarity |
NPD2533 |
Approved |
0.8828 |
High Similarity |
NPD2532 |
Approved |
0.8671 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8487 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.828 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8228 |
Intermediate Similarity |
NPD5711 |
Approved |
0.8228 |
Intermediate Similarity |
NPD5710 |
Approved |
0.8228 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8207 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.817 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8151 |
Intermediate Similarity |
NPD5405 |
Approved |
0.8151 |
Intermediate Similarity |
NPD5408 |
Approved |
0.8151 |
Intermediate Similarity |
NPD5404 |
Approved |
0.8151 |
Intermediate Similarity |
NPD5406 |
Approved |
0.8129 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8086 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8075 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8041 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8027 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8027 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7962 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7961 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7959 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7945 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7933 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7911 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7877 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7871 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7834 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7831 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7815 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7808 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7799 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7756 |
Intermediate Similarity |
NPD3226 |
Approved |
0.775 |
Intermediate Similarity |
NPD3749 |
Approved |
0.775 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7671 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7667 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7662 |
Intermediate Similarity |
NPD6799 |
Approved |
0.766 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7632 |
Intermediate Similarity |
NPD2800 |
Approved |
0.763 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7626 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7613 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7602 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7584 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7576 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7569 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7568 |
Intermediate Similarity |
NPD943 |
Approved |
0.7551 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD6099 |
Approved |
0.755 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7548 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7529 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7518 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7516 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7516 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7516 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD37 |
Approved |
0.7485 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7469 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7469 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7453 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7452 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7447 |
Intermediate Similarity |
NPD5691 |
Approved |
0.744 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7439 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7432 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD920 |
Approved |
0.74 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7396 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7389 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7379 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7378 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7353 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7353 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7315 |
Intermediate Similarity |
NPD411 |
Approved |
0.7315 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7314 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7273 |
Intermediate Similarity |
NPD919 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7247 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7247 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7241 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7235 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7213 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7203 |
Intermediate Similarity |
NPD9268 |
Approved |
0.72 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7192 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7181 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7174 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7174 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7172 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7172 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7168 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD74 |
Approved |
0.7153 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7127 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7127 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7105 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7101 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.708 |
Intermediate Similarity |
NPD9263 |
Approved |
0.708 |
Intermediate Similarity |
NPD9264 |
Approved |
0.708 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7059 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7055 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7051 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD520 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7032 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7027 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7027 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7027 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7025 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD3400 |
Discontinued |
0.702 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD1613 |
Approved |
0.6993 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD4477 |
Approved |
0.6987
|
Remote Similarity |
NPD2531 |
Phase 2 |